The global Sanger Sequencing Market is projected to reach USD 12.36 billion by 2032, growing at a CAGR of 18.63% from USD 2.90 billion in 2023. The U.S. market is expected to climb from USD 1.04 billion in 2023 to USD 4.25 billion by 2032, advancing at a CAGR of 16.89% over the forecast period.

Sanger sequencing remains crucial in clinical diagnostics and life sciences research, with precision and cost-efficiency demanded in mutation detection, microbial identification, and NGS result validation. Despite NGS proliferation, Sanger’s accuracy and reliability make it indispensable in targeted applications like oncology and gene-editing validation.

The U.S. market benefits from early sequencing technology adoption and continuous R&D investments, integrating Sanger sequencing in routine diagnostics for hereditary cancer screening, pharmacogenomics, and neurogenetics. Reagents and consumables dominate the market, with the instruments segment expected to grow due to increased installations in diagnostics laboratories and academic institutions.

Capillary electrophoresis remains dominant in Sanger sequencing workflows, while automated electrophoresis is fastest-growing, catering to the high demand for rapid sample turnover in clinical laboratories. Clinical diagnostics and pharmacogenomics are leading application segments, showcasing Sanger sequencing’s accuracy in genetic mutation validation and drug response profiling.

North America led the global Sanger sequencing market in 2023, with Asia Pacific projected as the fastest-growing region by 2032. Major players like Thermo Fisher Scientific and Eurofins Genomics drive market growth with advancements in sequencing technology and infrastructure investments in genomic labs.

Recent developments include the introduction of new Sanger sequencing services in the UK and India, along with the availability of sequencing kits responding to rising demand in Asia. Major players like Thermo Fisher Scientific, Eurofins Scientific, and Illumina are key contributors to the Sanger sequencing market’s growth and innovation.

Read more at GlobeNewswire: Sanger Sequencing Market Set to Surpass USD 12.36 Billion